Exenatide improves hypogonadism and attenuates inflammation in diabetic mice by modulating gut microbiota

Yuping Chen, Anmei Shu, Ming Jiang, Jinjin Jiang, Qiu Du, Tianbao Chen, Chris Shaw, Wengang Chai, TianQi Chao, Xiangzhe Li, Qin Wu, Cuixiang Gao

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

With the rising incidence of diabetes and its onset at a younger age, the impact on the male reproductive system has gradually gained attention. Exenatide is a glucagon-like peptide-1 receptor agonist effective in the treatment of diabetes. However, its role in diabetes-induced reproductive complications has rarely been reported. The study aimed to investigate the mechanism by which exenatide improved diabetic hypogonadism by regulating gut microbiota (GM) mediated inflammation. C57BL/6J mice were equally divided into normal control (NC), diabetic model control (DM) and exenatide-treated (Exe) groups. Testicular, pancreatic, colonic, and fecal samples were collected to assess microbiota, morphologic damage, and inflammation. Exenatide significantly reduced the fasting blood glucose (FBG) level in diabetic mice, increased the testosterone level, ameliorated the pathological morphological damage of islet, colon, and testes, and reduced the expression of pro-inflammatory factors, tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6 in colon and testis. Furthermore, exenatide significantly reduced the abundance of some pathogenic bacteria, such as Streptococcaceae and Erysipelotrichaceae, and increased that of beneficial bacteria Akkermansia. Probiotics, such as Lactobacillus were negatively correlated with TNF-α, nuclear factor-kappa-B (NF-κB), IL-6, and FBG. Conditional pathogenic bacteria such as Escherichia/Shigella Streptococcus were positively correlated with TNF-α, NF-κB, IL-6, and FBG. The fecal bacteria transplantation experiment revealed that the abundance of pathogenic bacteria, Peptostreptococcaceae, significantly decreased from Exe group mice to pseudo-sterile diabetic mice, and the pathological damage to testes was also alleviated. These data suggested the protective effects of exenatide on male reproductive damage induced by diabetes by regulating GM.
Original languageEnglish
Article number110339
Number of pages9
JournalInternational immunopharmacology
Volume120
Early online date19 May 2023
DOIs
Publication statusPublished - 01 Jul 2023
Externally publishedYes

Keywords

  • Diabetes mellitus
  • Exenatide
  • Hypogonadism
  • Gut microbiota
  • Inflammation

Fingerprint

Dive into the research topics of 'Exenatide improves hypogonadism and attenuates inflammation in diabetic mice by modulating gut microbiota'. Together they form a unique fingerprint.

Cite this